Oncobiologics is a privately held biopharmaceutical company developing a pipeline of biosimilars and next generation biotherapeutics. Formed by a team of leading industry experts from firms such as Eli Lilly, Bristol-Myers Squibb, Amgen, Genentech, Merck and Pfizer, Oncobiologics operates from a state-of-the-art 40,000 sq. ft. fully integrated R&D and Manufacturing facility in Cranbury, NJ.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 07/16/14 | undisclosed | Strategic |
Strides Arcolab | undisclosed |
| 07/28/15 | $31,000,000 |
Cormorant Global Healthcare Master Fund Longwood Capital Partners MIH Fund OSSB Pharma Fund Perceptive Advisors Proximare Lifesciences Fund VenBio | undisclosed |
